Hung‐Tien Kuo

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Association of Fluid Overload with Cardiovascular Morbidity and All-Cause Mortality in Stages 4 and 5 CKD

Yi‐Chun Tsai, Yi‐Wen Chiu, Jer‐Chia Tsai et al. · Clinical Journal of the American Society of Nephrology · 2014 · 155 citations · Full text

Risk Factors for New-Onset Diabetes Mellitus in Adult Liver Transplant Recipients, an Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing Database

Hung‐Tien Kuo, Marcelo Santos Sampaio, Xiaoyi Ye et al. · Transplantation · 2010 · 153 citations

Organ Donation, Liver Transplant Recipients, Solid Organ Transplantation +16

Associations of Pretransplant Diabetes Mellitus, New-Onset Diabetes After Transplant, and Acute Rejection With Transplant Outcomes: An Analysis of the Organ Procurement and Transplant Network/United Network for Organ Sharing (OPTN/UNOS) Database

Hung‐Tien Kuo, Marcelo Santos Sampaio, Flavio Vincenti et al. · American Journal of Kidney Diseases · 2010 · 126 citations

Islet Transplantation, Transplant Outcomes, Transplantation +8